Trials / Sponsors / Ascendis Pharma Oncology Division A/S
Ascendis Pharma Oncology Division A/S
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 / Phase 2 | 2022-01-11 |
| Terminated | A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 / Phase 2 | 2021-03-18 |